AIM ImmunoTech receives NYSE American notice of delisting and appeal

Seeking Alpha News (Fri, 04-Apr 4:55 PM)

  • AIM ImmunoTech (NYSE:AIM) said on Friday that it has received notification from NYSE American that it had suspended trading of the company’s common stock and of its determination to commence delisting proceedings due to the low selling price of the company’s common stock. 
  • The company plans to appeal the determination to the exchange’s Listing Qualifications Panel. 
  • The company’s common stock is expected to begin trading on the Pink Open Market on April 7, 2025.